Lives unaffected by cystic fibrosis

Clinical Improvement

Cystic Fibrosis Australia is committed to improving clinical practice and patient outcomes through our clinical improvement programmes and research. 

We are committed to the goal of extending life expectancy from 47 to 55 years by 2026. To achieve this we maintain our quest for funding to ensure our clinical improvement assets such continue to thrive.

These include the Australian Cystic Fibrosis Data Registry (ACFDR), Peer Reviews, Standards of Care, Infection Control Guidelines, Transition Guidelines and Centre Directors Forums.

Everyone at Cystic Fibrosis Australia (CFA) is focused on fulfilling our mission to deliver clinical improvement and research as the peak national body, supporting state and territory members with their goals to enhance the quality of life of people with cystic fibrosis.

If you would like to support CFA’s Clinical Improvement initiatives such as the Data Registry, Peer Reviews and Infection Control Guidelines please DONATE HERE>

Cystic Fibrosis Australia endorses Inc.
The education provided has been developed by physiotherapists in Australia and New Zealand.
The website is not intended to replace your usual CF care.
It is important you read and agree to the terms of use.
Please visit



Australasian Social Work Guidelines

This document represents the first set of comprehensive clinical guidelines for social work in cystic fibrosis (CF) in Australia and New Zealand.

Download the Australasian Social Work Guidelines (PDF)

Physiotherapy for Cystic Fibrosis

This Clinical Practice Guideline has been written by physiotherapists who are experienced in the management of cystic fibrosis in Australia and New Zealand.

View the guidelines>

Infection Control for Health workers - Position Paper

Work environment risks for health care workers with cystic fibrosis. 

Download the Position Statement>

Australian Standards of Care for CF-Related Diabetes

Multiple guidelines have been published over the last few years for the diagnosis and management of cystic fibrosis (CF) and cystic fibrosis related diabetes (CFRD), although some of the recommendations are based on extrapolation from other forms of diabetes and/or expert opinions. This document seeks to combine the guidelines to provide an Australian approach to the management of CFRD and establish the guidelines within the Australian CF Standards of Care.

View the guidelines>